| Product Code: ETC10123677 | Publication Date: Sep 2024 | Updated Date: Dec 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Zambia continued to see significant imports of oral hypoglycemic agents (OHAs) primarily from India, South Africa, China, USA, and Denmark. The market concentration, as measured by the HHI, remained high, indicating a notable level of dominance by these top exporting countries. Despite a modest Compound Annual Growth Rate (CAGR) of 0.24% from 2020 to 2024, the growth rate surged by 21.93% from 2023 to 2024, suggesting a recent uptick in demand for OHAs in Zambia. This trend underscores the importance of monitoring market dynamics and supplier relationships in the pharmaceutical sector.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Zambia Oral Hypoglycemic Agents (OHAs) Market Overview |
3.1 Zambia Country Macro Economic Indicators |
3.2 Zambia Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, 2021 & 2031F |
3.3 Zambia Oral Hypoglycemic Agents (OHAs) Market - Industry Life Cycle |
3.4 Zambia Oral Hypoglycemic Agents (OHAs) Market - Porter's Five Forces |
3.5 Zambia Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume Share, By Type of Product, 2021 & 2031F |
3.6 Zambia Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 Zambia Oral Hypoglycemic Agents (OHAs) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in Zambia |
4.2.2 Growing awareness about the importance of diabetes management |
4.2.3 Rising disposable income leading to higher healthcare expenditure |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities in remote areas |
4.3.2 High cost of oral hypoglycemic agents |
4.3.3 Lack of skilled healthcare professionals |
5 Zambia Oral Hypoglycemic Agents (OHAs) Market Trends |
6 Zambia Oral Hypoglycemic Agents (OHAs) Market, By Types |
6.1 Zambia Oral Hypoglycemic Agents (OHAs) Market, By Type of Product |
6.1.1 Overview and Analysis |
6.1.2 Zambia Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, By Type of Product, 2021- 2031F |
6.1.3 Zambia Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, By Sulfonylureas, 2021- 2031F |
6.1.4 Zambia Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, By Metformin, 2021- 2031F |
6.1.5 Zambia Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, By Thiazolidinediones, 2021- 2031F |
6.1.6 Zambia Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, By Alpha-Glucosidase Inhibitors, 2021- 2031F |
6.2 Zambia Oral Hypoglycemic Agents (OHAs) Market, By End Users |
6.2.1 Overview and Analysis |
6.2.2 Zambia Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, By Hospital, 2021- 2031F |
6.2.3 Zambia Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, By Clinics, 2021- 2031F |
7 Zambia Oral Hypoglycemic Agents (OHAs) Market Import-Export Trade Statistics |
7.1 Zambia Oral Hypoglycemic Agents (OHAs) Market Export to Major Countries |
7.2 Zambia Oral Hypoglycemic Agents (OHAs) Market Imports from Major Countries |
8 Zambia Oral Hypoglycemic Agents (OHAs) Market Key Performance Indicators |
8.1 Average number of diabetes screenings conducted annually |
8.2 Percentage of diabetic patients using oral hypoglycemic agents as part of their treatment |
8.3 Rate of adoption of new oral hypoglycemic agents in the market |
9 Zambia Oral Hypoglycemic Agents (OHAs) Market - Opportunity Assessment |
9.1 Zambia Oral Hypoglycemic Agents (OHAs) Market Opportunity Assessment, By Type of Product, 2021 & 2031F |
9.2 Zambia Oral Hypoglycemic Agents (OHAs) Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 Zambia Oral Hypoglycemic Agents (OHAs) Market - Competitive Landscape |
10.1 Zambia Oral Hypoglycemic Agents (OHAs) Market Revenue Share, By Companies, 2024 |
10.2 Zambia Oral Hypoglycemic Agents (OHAs) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |